IAGC 2022
IAGC International Aesthetic Gynecology Congress: 4-6th November 2022 @Mövenpick Grand Al Bustan, Dubaï We can’t wait to see you again at IACG, both, booth #20 !
Read more...
IMS 2022
IMS 18st World congress on menopause: 26-29th October 2022 @Lisbon Congress Center, Lisbon, Portugal We can’t wait to see you again at IMS, booth #18 !
ESAG 2022
ESAG European Society of Aesthetic Gynecology: 21-22nd October 2022 @Queen Elizabeth II Centre, London We can’t wait to see you again at ESAG, Booth #4 !
MEIDAM 2022
MEIDAM International Congress : 23th to 25th September @ Dubai We can’t wait to see you again at MEIDAM, InterContinental Dubai – Festival City, Booth #70 ! More informations
ISAPS 2022
ISAPS World Congress : 21th to 24th September @ Istanbul We can’t wait to see you again at ISAPS, Istanbul Lutfi Kirdar International Convention and Exhibition Centre, Booth #48 ! More informations
5CC 2022
14th 5CC World Congress : 1st to 4th September @ Barcelona We can’t wait to see you again at the 5CC, Centre de Convencions Internacional de Barcelona (CCIB) Booth #03 ! More informations
Randomized clinical trial (RCT), Knee osteoarthritis
Efficacy and safety of the combination of PRP + non-crosslinked hyaluronic acid versus hyaluronic acid, in mono-injection, in symptomatic knee osteoarthritis, randomized controlled phase III trial, single blind. The purpose of this randomized, controlled, multicenter, non-inferiority clinical trial was to compare the efficacy and safety of the combination of PRP and non-crosslinked hyaluronic acid (Cellular… Continue reading Randomized clinical trial (RCT), Knee osteoarthritis
IMCAS 2022
Friday 3rd to Sunday 5th June @ Paris In addition to educational grant session, RegenLab is organizing trainings sessions on Saturday June 4th – Room 341 Completed program : 10:30am -11:15amMedical Aesthetics are for men as well, Dr. Sandrine Grept-Locher – Aesthetic Medicine, Switzerland 11 :30am -12:15amRegenPRP for infection prevention, healing promotion & regenerationDr Ali… Continue reading IMCAS 2022
ORthoBIologics InitiaTive (ORBIT) Consensus from ESSKA – Section 1
PRP – Rational/Indication Does current clinical evidence support the use of PRP for knee OA For which degrees of knee OA is PRP best indicated? Can PRP be used in severe knee OA (KL4)? Is PRP indicated for the treatment of Patellofemoral OA (PFOA)? Are there specific contraindications for the use of PRP for knee… Continue reading ORthoBIologics InitiaTive (ORBIT) Consensus from ESSKA – Section 1
ORthoBIologics InitiaTive (ORBIT) Consensus from ESSKA
In April 2022, following the annual ESSKA congress, a group of experts published an important document stating their recommendations on the use of PRP in the management of knee osteoarthritis. This is a consensus paper which was obtained after more than 2 years of deliberations on the subject, answering 28 specific questions for which an… Continue reading ORthoBIologics InitiaTive (ORBIT) Consensus from ESSKA